See more : Wolters Kluwer N.V. (WOLTF) Income Statement Analysis – Financial Results
Complete financial analysis of S&S Healthcare Holding Ltd. (4198.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of S&S Healthcare Holding Ltd., a leading company in the Healthcare industry within the Healthcare sector.
- Canature Health Technology Co., Ltd. (300272.SZ) Income Statement Analysis – Financial Results
- Tian Tu Capital Co Ltd (1973.HK) Income Statement Analysis – Financial Results
- Slitevind AB (SLITE.ST) Income Statement Analysis – Financial Results
- HL Corp (Shenzhen) (002105.SZ) Income Statement Analysis – Financial Results
- QualTek Services Inc. (QTEKW) Income Statement Analysis – Financial Results
S&S Healthcare Holding Ltd. (4198.TWO)
About S&S Healthcare Holding Ltd.
S&S Healthcare Holding Ltd. focuses on the research and development, manufacture, and sale of medical imaging devices in Taiwan, the United States, Switzerland, and internationally. It develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd. and changed its name to S&S Healthcare Holding Ltd. in August 2020. S&S Healthcare Holding Ltd. was founded in 1988 and is headquartered in Taipei, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 275.11M | 254.44M | 122.35M | 101.36M | 181.73M |
| Cost of Revenue | 239.46M | 216.05M | 130.29M | 124.76M | 167.12M |
| Gross Profit | 35.66M | 38.39M | -7.93M | -23.40M | 14.61M |
| Gross Profit Ratio | 12.96% | 15.09% | -6.48% | -23.09% | 8.04% |
| Research & Development | 15.11M | 21.38M | 24.33M | 36.17M | 34.44M |
| General & Administrative | 68.53M | 68.32M | 54.83M | 56.31M | 68.06M |
| Selling & Marketing | 43.37M | 45.60M | 16.78M | 17.17M | 42.94M |
| SG&A | 111.90M | 113.92M | 71.61M | 73.48M | 104.47M |
| Other Expenses | 0.00 | 42.40M | 9.47M | 21.21M | 0.00 |
| Operating Expenses | 128.58M | 135.30M | 95.93M | 109.65M | 138.91M |
| Cost & Expenses | 368.03M | 351.35M | 226.22M | 234.42M | 306.03M |
| Interest Income | 593.00K | 119.00K | 161.00K | 280.00K | 164.00K |
| Interest Expense | 5.24M | 2.37M | 1.74M | 1.92M | 2.09M |
| Depreciation & Amortization | 25.71M | 34.39M | 22.02M | 19.42M | 13.79M |
| EBITDA | 133.81M | -33.61M | -71.64M | -93.48M | -123.69M |
| EBITDA Ratio | 48.64% | -7.86% | -59.03% | -90.91% | -60.81% |
| Operating Income | -92.92M | -54.40M | -94.24M | -111.56M | -124.30M |
| Operating Income Ratio | -33.78% | -21.38% | -77.02% | -110.07% | -68.40% |
| Total Other Income/Expenses | 195.78M | 26.54M | 8.47M | 18.24M | -27.98M |
| Income Before Tax | 102.86M | -70.37M | -95.39M | -114.82M | -152.28M |
| Income Before Tax Ratio | 37.39% | -27.66% | -77.97% | -113.27% | -83.80% |
| Income Tax Expense | -33.00K | -1.21M | 0.00 | 50.00K | 99.00K |
| Net Income | 103.61M | -66.89M | -95.39M | -114.87M | -152.38M |
| Net Income Ratio | 37.66% | -26.29% | -77.97% | -113.32% | -83.85% |
| EPS | 4.49 | -3.77 | -6.52 | -9.34 | -17.91 |
| EPS Diluted | 4.49 | -3.77 | -6.52 | -9.34 | -17.91 |
| Weighted Avg Shares Out | 23.06M | 17.72M | 14.64M | 12.30M | 8.51M |
| Weighted Avg Shares Out (Dil) | 23.06M | 17.72M | 14.64M | 12.30M | 8.51M |
Source: https://incomestatements.info
Category: Stock Reports